Dendrobium

Dendrobium

1. Identity and Botanical Classification

Genus and family: Dendrobium is a large genus of epiphytic and lithophytic orchids belonging to the family Orchidaceae. Orchidaceae is the largest family group among angiosperms, as well as the most highly evolved family of the flowering plants, with approximately 25,000 to 35,000 species under 750 to 900 genera. Within this family, Dendrobium species, commonly known as "Shihu" or "Huangcao," is the second largest genus in Orchidaceae.

Species diversity: There are about 1,500 species of Dendrobium around the world, and 50 of them have been found to be medicinally valuable in China. There are 78 species of Dendrobium in China, 14 of which are endemic to China.

Key medicinal species: The genus contains numerous species, but the most widely studied and referenced in pharmacopoeias include:

• Dendrobium nobile Lindl. — also known as Noble Dendrobium or Jin Chai Shi Hu (金钗石斛) in Chinese; a perennial epiphytic herb recorded in the Chinese Pharmacopoeia.
• Dendrobium officinale Kimura et Migo — believed in traditional Chinese medicine (as "Tie-pi-Shi-hu" in TCM) to have the best medicinal qualities, including immunomodulatory, antineoplastic, antioxidative, and antimutagenic activities.
• Dendrobium chrysotoxum, D. loddigesii, D. moniliforme, D. fimbriatum, and D. candidum are among numerous other species that have been investigated phytochemically.

Pharmaceutical designations and common names: The common English name is Dendrobium; its Latin pharmaceutical designation is Herba dendrobii. It is also known as shi hu (石斛). The dried or fresh stems constitute the official medicinal material, referred to as Dendrobii Caulis in pharmacopeial texts.

Habitat and ecology: Most Dendrobium species grow best in relatively high and mountainous areas, at 1400–1600 m above sea level, at a mild temperature, and in a humid and foggy environment. Dendrobium orchids can be categorized as epiphytic (growing on trees or shrubs), saprophytic (growing on dead and decaying matter), or terrestrial (growing on the ground). In China, the herb is cultivated predominantly in Yunnan, Sichuan, and Guizhou provinces.

Common forms and preparations: The fresh or dried stems of many Dendrobium species are well known as one of the most expensive tonics in traditional Chinese medicine. In practice, the plant is prepared as decoctions, teas, tinctures, concentrated granules, and powdered extracts. China has initiated trials in several provinces to develop the stems, leaves, and flowers of Dendrobium as local specialty new food ingredients and health products. The stems, leaves, and flowers of D. officinale were approved by the National Health Commission of China as new food ingredients in 2013, 2017, and 2018, respectively. Internationally, Dendrobium extract also appears in capsules and as an ingredient in pre-workout sports supplements, a context that has attracted distinct regulatory scrutiny.

2. Traditional and Historical Use

The history of the utilization of medicinal Dendrobium in China spans approximately 1,500 years, and the first record of its use was found in the Shen Nong Ben Cao Jing (Shennong's Classic of Materia Medica). The earliest records of Dendrobium utilization in China date to "Shen Nong's Herbal Classic" (the Eastern Han Dynasty), written nearly 2,300 years ago. A high proportion of species native to China from the genus have been used as folk medicine for more than 2,300 years.

In the Shen Nong Ben Cao Jing, China's earliest materia medica, shi hu was classified as a "superior" (上品) herb, meaning it was considered safe for long-term use and capable of nourishing life. As early as 200 B.C., the Chinese pharmacopoeia "The Sang Nung Pen Tsao Ching" mentioned Dendrobium as a source of tonic, astringent, analgesic, and anti-inflammatory substances.

In the Song Dynasty (960–1279 A.D.), the medicinal uses of orchids, including Dendrobium species, were described in the herbal text Zheng Lei Ben Cao. The Ming Dynasty (1368–1644) saw further documentation of orchid-based medicine.

TCM classification and functions: The fresh or dried stem of many Dendrobium species are regarded as "superior grade" tonics in Traditional Chinese Medicine (TCM), with traditional properties of nourishing the kidney, moisturizing the lung, benefiting the stomach, promoting the production of body fluids, and clearing heat. Dendrobium nobile, known as "shi hu" or "shi hu gen," is used because of its tonic, nourishing, and replenishing properties. It is used to treat various health conditions such as respiratory and digestive disorders, providing immune support and helping with physical endurance and skin health. D. nobile is associated with the Stomach, Kidney, and Lung meridians.

Taoist tradition: Shi hu was ranked first among the "Nine Celestial Herbs" (九大仙草) in the Dao Zang (道藏) of Taoist tradition, placing it above even Ginseng, Lingzhi, and Cordyceps. Taoist monks reportedly drank Shi hu tea daily as a longevity tonic and to cultivate Jing (Essence).

Status among classical Chinese medicines: Dendrobium, together with Dong Chong Xiao Cao (Cordyceps sinensis), Ren Shen (Radix Ginseng), and Ling Zhi (Ganoderma lucidum), have been regarded as precious and top-grade traditional Chinese medicines in China for thousands of years.

Ayurvedic use: In the Ayurvedic system of medicine, related orchid species including Dendrobium alpestre are used; these were commonly applied as astringents, aphrodisiacs, and in treating asthma and bronchitis.

Culinary use: In Chinese cuisine, shi hu is often made into dishes. It can aid digestion and stimulate the production of stomach juice. It is added to soups, made into tea, and cooked with traditional desserts.

3. Key Chemical Constituents and Active Compounds

The phytochemistry of Dendrobium is complex and varies substantially between species. At present, 450 compounds including sesquiterpenoids, lignans, phenolic compounds, phenanthrene compounds, bibenzyls, polysaccharides, and flavonoids have been isolated and identified from at least 50 species of Dendrobium.

3.1 Alkaloids

Alkaloids were the earliest compounds isolated from Dendrobium medicinal materials. In 1932, the Japanese scholar Suzuki first isolated an alkaloid from D. nobile, which was named dendrobine. Dendrobine is a characteristic index component used for evaluating the quality of D. nobile. It is a sesquiterpenoid alkaloid with a unique picrotoxane-type structure.

The structural and molecular formula of various alkaloids have been identified, including dendrobine, nobilonine, dendroxine, dendrine, 6-hydroxydendroxine, and 8-hydroxydendroxine. Dendrobium nobile Lindl. alkaloids (DNLAs) contain a variety of monomer components, including dendrobine (DDB, comprising approximately 92.6%), dendrobine-N-oxide (3.3%), nobilonine (2.0%), dendroxine (0.9%), 6-hydroxynobilonine (0.32%), and 13-hydroxy-14-oxodendrobine (0.07%).

Dendrobine is used as a quality marker for the quality control of D. nobile according to the Chinese Pharmacopoeia. The alkaloids of Dendrobium nobile Lindl. have anti-tumor, hypertension-reducing, and nervous system-protecting effects.

3.2 Polysaccharides

Polysaccharides of D. officinale are mainly composed of glucose and mannose (mannopyranose:glucopyranose = 2.01:1.00–8.82:1.00), along with galactose, xylose, arabinose, and rhamnose in different molar ratios and types of glycosidic bonds. Among 19 species of Dendrobium, D. officinale has the highest polysaccharide content, up to 22.49%, while D. nobile has the highest alkaloid content, up to 43.6 mg/100 g.

Dendrobium officinale polysaccharide (DOP), a significant active ingredient extracted from D. officinale, has been demonstrated to possess considerable potential in regulating the immune function of the body. Studies indicate that DOPs exhibit various physiological effects, including antioxidant, antitumor, antimetabolic disease properties, and the regulation of intestinal microecology.

3.3 Bibenzyls

D. nobile has been found to contain various bioactive compounds, including alkaloids, bibenzyl, phenanthrene, phenylpropanoids, and polysaccharides. Notable bibenzyls include gigantol, moscatilin, chrysotoxine, batatasin III, and crepidatin. Densiflorol B and phoyunnanin E have shown the strongest antimalarial activity, while gigantol and batatasin III exhibited moderate antimalarial activity in bioassay-guided isolation studies.

3.4 Phenanthrenes and Fluorenones

Phenanthrene has a wide range of biological activities, but has only been reported in a few families in the plant kingdom; orchids are the most crucial source of natural phenanthrene. Fluorenones are another class of compounds isolated from multiple Dendrobium species, with some demonstrating cytotoxic activity in laboratory models.

3.5 Other Phenolic Compounds

Ethanolic extracts of Dendrobium orchid pseudobulbs from species including D. chrysotoxum, D. fimbriatum, D. lindleyi, and D. pulchellum were found to contain caffeic acid, gallic acid, quercetin, rutin hydrate, and vanillin. Luteolin was shown in D. fimbriatum and D. lindleyi extracts.

3.6 Summary of Major Constituent Classes

• Sesquiterpenoid alkaloids: Dendrobine, dendroxine, nobilonine, dendrine (characteristic of D. nobile)
• Polysaccharides: Mannose-glucose heteropolysaccharides (characteristic of D. officinale)
• Bibenzyls: Gigantol, moscatilin, batatasin III, crepidatin, chrysotoxine
• Phenanthrenes: Species-specific; multiple isolated structures
• Flavonoids: Quercetin, luteolin, rutin, and others
• Phenolic acids: Caffeic acid, gallic acid, vanillin
• Fluorenones, coumarins, lignans, steroids

4. Established and Proposed Mechanisms of Action

4.1 Immunomodulation

Dendrobium polysaccharides (DP) stimulate immune activity by activating the extracellular signal-regulated kinase 1/2 (ERK 1/2) and nuclear factor-kappa B (NF-κB) signaling pathways. Some subfractions of DP exhibit immunomodulatory activities in vivo and enhance immune responses by increasing the proliferation of immune cells, the secretion of cytokines such as TNF-α, the production of nitric oxide (NO), and phagocytosis. One polysaccharide fraction demonstrated significant immunomodulatory effects, notably enhancing the phagocytic activity of macrophages and increasing the cytotoxicity of NK cells.

4.2 Anti-tumor Mechanisms

Accumulating evidence suggests that the active components of Dendrobium possess significant inhibitory effects on the viability of cancer cells, as evident from in vivo and in vitro experiments; these include suppression of cancer cell growth and proliferation, inhibition of epithelial-mesenchymal transition (EMT), induction of apoptosis, inhibition of tumor angiogenesis, and reinforcement of cisplatin-induced apoptosis.

The representative alkaloid dendrobine, based on the picrotoxane skeleton, has been found to exert inhibitory effects on various tumors. The primary anti-tumor mechanism of dendrobine involves inhibiting the activation of proto-oncogenes and increasing the expression of oncogenes, thus suppressing the abnormal proliferation and differentiation of cells. Fat-soluble alkaloids extracted from Dendrobium nobile Lindl. were found to induce the apoptosis of human colorectal cancer HT-29 cells with an IC50 value of 0.72 mg/ml at 48 h, with cell cycle arrest in G2 phase; the extraction decreased mitochondrial membrane potential and induced ROS accumulation by increasing expression of apoptotic proteins including Caspase-9, Caspase-3, and intracellular cytochrome C, which may be related to the mitochondria-mediated apoptotic pathway.

4.3 Neuroprotective Mechanisms

The mechanisms by which Dendrobium nobile Lindl. alkaloid has been reported to improve cognitive dysfunction in Alzheimer's disease animal models may be associated with extracellular amyloid plaque production, regulation of tau protein hyperphosphorylation, inhibition of neuroinflammation and neuronal apoptosis, activation of autophagy, and enhanced synaptic connections. DNLA suppressed cell membrane lysis and cell swelling, and inhibited expression of the pyroptosis mediator GSDMD-N. DNLA-mediated neuroprotection was dependent on the inhibition of NLRP3 inflammasome activation, as evidenced by reduced pro-inflammatory cytokines (IL-18 and IL-1β) and inhibited expression of related proteins.

4.4 Hypoglycemic Mechanisms

DNLA (total alkaloids) reduces blood glucose levels in animal models of type 2 diabetes mellitus such as db/db and KK-Ay mice, improves insulin resistance, and has a protective effect on pancreatic β cells. It increases the phospho-INSR level and IRS-1, and activates Akt. In a prediabetic mouse model, 200 mg/kg/d of D. officinale polysaccharide (DOP) reduced the relative risk of developing type 2 diabetes mellitus from prediabetes by 63.7%. DOP decreased LPS levels and inhibited TLR4 expression by regulating gut microbiota composition, thereby relieving inflammation.

4.5 Gastroprotective Mechanisms

Studies aimed to investigate the protective effects and molecular mechanisms of Dendrobium officinale polysaccharides on gastric mucosal injuries used an ethanol-induced rat model; inflammatory markers including IL-6, epidermal growth factor receptor (EGFR), and thyroid transcription factor 1 (TFF-1) in serum were measured. Gastroprotective efficacy of fresh D. officinale preparations was demonstrated to involve antioxidation activity and regulation of the Keap1-Nrf2 signaling pathway.

5. Scientific Evidence by Area of Use

Important caveat on evidence quality: The overwhelming majority of pharmacological studies on Dendrobium have been conducted in cell cultures (in vitro) and animal models (in vivo). Human clinical trials are extremely sparse across virtually all studied indications. The evidence reviewed here is therefore largely preclinical, and this limitation is noted under each area below.

5.1 Immunomodulation

Various activities of D. officinale polysaccharides have been demonstrated by modern pharmacology research; these polysaccharides possess antitumor, hypolipidemic, antifatigue, antioxidant, hypoglycemic, gastric ulcer protective, antihypertensive, and immunoenhancement effects. In a study exploring anti-tumor and immunomodulation activity, DOP could inhibit the growth of S180 tumors by promoting splenocyte proliferation, enhancing NK cell and CTL activity, and increasing non-specific and tumor antigen-specific antibody levels in tumor-bearing mice. These findings suggested that DOP might be a potential antitumor agent with immunomodulatory activity.

Evidence strength: This area is supported primarily by in vitro and animal studies. Mechanistic pathways (ERK1/2, NF-κB) have been characterized in cell lines. No controlled human clinical trials are available as of the time of writing.

5.2 Anti-tumor and Anti-cancer Activity

Research on the clinical application of Dendrobium in antitumor therapy has gained increasing attention. It exerts pharmacological activities such as antitumor and hypoglycemia effects, with main active components being alkaloids, polysaccharides, and terpenoids. In vitro, the combined treatment using the sesquiterpene alkaloid dendrobine and cisplatin was effective for inhibiting non-small cell lung cancer cells (NSCLC) in vitro and in vivo; cytotoxicity was induced via stimulation of c-jun NH2-terminal kinase (JNK)/p38 stress signaling pathways, and the expression change of pro-apoptotic proteins Bax and Bim further led to apoptosis.

Evidence strength: Entirely preclinical (in vitro and animal models). Despite promising mechanistic data, no human clinical trials of Dendrobium constituents as cancer treatments have been confirmed in the published literature.

5.3 Blood Glucose Regulation and Diabetes

A type 2 diabetic mellitus (T2DM) rat model was established using the high-fat diet (HFD) and streptozotocin (STZ) method. These T2DM rats were treated with D. nobile extract and D. nobile polysaccharide for two months by gavage. Results showed that a total of 39 chemical constituents were identified; the extract and polysaccharide could significantly ameliorate body weight, hyperglycemia, insulin resistance, dyslipidemia, and morphological impairment of the liver and pancreas in the T2DM rats.

DNLA (total alkaloids from D. nobile) has shown significant therapeutic effects on diabetes in experimental models. The mechanisms include modulation of insulin signaling, gut microbiota composition, and beta-cell protection.

Evidence strength: Strong preclinical evidence from multiple rodent studies. The Frontiers in Endocrinology 2025 review on D. officinale polysaccharides and diabetes also summarized mechanistic gut-microbiota-mediated pathways. However, more clinical studies are in demand for the risk assessment of humans under exposure to Dendrobium officinale. No robust human clinical trials have been published demonstrating glycemic benefit in humans.

5.4 Neuroprotection and Neurodegenerative Disease

Several reports have demonstrated the neuroprotective effects of DNLA against memory deficits, neuronal and synaptic loss, inhibition of tau protein hyperphosphorylation, and apoptosis in the hippocampus. Previous studies demonstrated that DNLAs have neuroprotective activity in both in vivo and in vitro models of Alzheimer's disease. DNLAs, as autophagy inducers, can promote lysosomal acidification and the clearance of toxic protein aggregates, increase the expression of neurotrophic factors, decrease neuronal apoptosis, and reduce hyperphosphorylation of tau proteins.

Substantial evidence from preclinical studies demonstrates that D. officinale polysaccharides exhibit multifaceted therapeutic properties, including anti-inflammatory responses, glycemic regulation, and immunomodulatory activities. A growing body of research is elucidating the neuroprotective mechanisms of these polysaccharides, providing scientific rationale for their potential in addressing age-related neurological disorders.

Evidence strength: This area is supported entirely by animal model research. The neuroprotective effects of Dendrobium nobile Lindl. alkaloid have not been studied in patients. All neuroprotection data come from rodent models of Alzheimer's disease and vascular dementia, with no published human trials.

5.5 Gastroprotective and Digestive Effects

Gastroprotective activity has been studied across multiple preclinical models. The potential of DOP to ameliorate gastric ulcers was investigated using an acetic-acid-induced gastric ulcer model in rats. Results demonstrated that DOP exerted a multifaceted protective effect against gastric ulcers, mitigating the deleterious impact on food intake and body weight. The gastroprotective efficacy of fresh D. officinale granule preparations was investigated in mice with alcoholic, indometacin, and reserpine gastric ulcer models, and in rats with acetic acid–induced chronic gastric ulcers.

Previous studies have shown prominent benefits of using D. officinale for the treatment of atrophic gastritis, low-grade fever, and mouth ulcers.

Evidence strength: Preclinical (animal model) evidence is substantial and mechanistically detailed. Some traditional clinical use documentation exists (atrophic gastritis), but no published controlled human clinical trials were identified in the sources reviewed.

5.6 Antioxidant Activity

The stem ethanolic extract of Dendrobium macrostachyum Lindl. possesses high phenolic content and antioxidant and anti-inflammatory activity; the stem ethanolic extract exhibited significant IC50 values of 10.21, 31.54, and 142.97 μg/ml for DPPH, ABTS radical scavenging, and reducing power activity, respectively.

Fermented D. officinale polysaccharide fractions showed significant inhibitions of inflammatory factors including MCP-1, TNF-α, NO, and IL-1β; they also recovered levels of filaggrin, aquaporin 3, and related markers, and exhibited remarkable reactive oxygen species (ROS) scavenging capacity with superior antioxidant activity. These fractions show dual anti-inflammatory and antioxidant properties, making them suitable as active ingredients for modulating epidermal inflammation and promoting skin barrier repair.

Evidence strength: In vitro antioxidant capacity is well-documented across multiple species and extract types. Translation to human clinical benefit is unproven.

5.7 Ocular Health (Dry Eye)

The active ingredients in Dendrobium, such as polysaccharides, alkaloids, and phenols, have anti-inflammatory, anti-tumour, and immunity-boosting effects. Dendrobium officinale extract can improve glandular secretion function, increase salivary secretion, and increase the expression level of water channel protein in salivary glands in patients with dry eye syndromes. The in vitro cytoprotective effect of Dendrobium extracts was investigated in sodium chloride–induced hyperosmotic conditions in human cornea keratocytes. Results showed that Dendrobium officinale Kimura et Migo water extract and Dendrobium loddigesii Rolfe extract produced protective effects.

Evidence strength: Preliminary in vitro and limited clinical observation. One study referenced patient-level effects on salivary gland secretion in dry-eye syndromes, but no large, randomized controlled trials were identified.

5.8 Skin Health

Dendrobium officinale polysaccharides have been found to possess hair growth–promoting, skin-moisturising, and antioxidant effects, which are highly valued by doctors and cosmetic engineers. Researchers discovered the reparative effect of D. officinale protocorms against oxidative damage caused by UV radiation. They compared D. officinale protocorms and matrixyl (a cosmetic peptide) on UV radiation–induced photodamage in hairless mice. Results revealed that D. officinale protocorms protected the skin from dryness and effectively reduced erythema by enhancing the antioxidant systems.

Evidence strength: In vitro and animal evidence. No randomized human cosmetic or dermatological trials were identified in the sources.

5.9 Antimicrobial and Antiparasitic Activity

A methanol extract from the whole plant of Dendrobium venustum exhibited significant antimalarial and anti-herpetic activities. Bioassay-guided isolation resulted in the identification of seven known phenolic compounds; densiflorol B and phoyunnanin E showed the strongest antimalarial activity with a high selectivity index. These findings are exploratory; no clinical antimalarial or antiviral applications have been developed from Dendrobium to date.

5.10 Athletic Performance Enhancement

Dendrobium is now an ingredient in some pre-workout dietary supplements marketed to enhance physical or athletic performance. However, little evidence indicates that Dendrobium is effective for this purpose. Dendrobium is appearing in pre-workout supplements used to boost physical and athletic performance, but there is no good scientific evidence to support these uses.

6. Dosage Forms and Reported Dosages

Dosage information varies by species, preparation, and source. The following are drawn from pharmacopeial guidance and preclinical study reports:

• According to the Pharmacopoeia of the People's Republic of China (China Pharmacopoeia Committee, 2020), the dosage of 6–12 g/day of D. officinale is considered appropriate.
• The daily intake should not exceed 12 g according to the Chinese Pharmacopoeia (2020 Edition).
• In the prediabetic mouse model study, 200 mg/kg/day of DOP was used, which reduced the relative risk of developing T2DM by 63.7%.
• In the T2DM rat model study, D. nobile extract and polysaccharide were administered for two months by gavage.
• In one acute toxicity study, the test article was orally administered once by gavage to male and female rats at doses of 0, 2,500, and 5,000 mg/kg body weight.

No validated human clinical dosage ranges for specific therapeutic indications have been established from the published peer-reviewed literature reviewed.

7. Safety Considerations

7.1 General Toxicological Safety

The chronic and acute risk quotients of common pesticides were quite low, indicating that Dendrobium officinale shows little toxicity as a dietary consumption in the general population. There are few reports of significant toxicity induced by the consumption of Dendrobium officinale.

Acute toxicity testing at 12.0 g/kg, genetic toxicity tests, and a 90-day feeding test at 1.08, 1.67, and 5.00 g/kg in rats indicated that D. officinale showed no noticeable signs of toxicity, genetic toxicity, or mutagenicity within the tested dose ranges.

Throughout an acute toxicity study period of D. moniliforme, no treatment-related deaths were observed and no adverse effects were noted in clinical signs, body weight, food consumption, serum biochemistry, organ weight, or gross findings at any dose tested. No toxic effects were detected in rats following ingestion of D. nobile extract at a dose level of 10 g/kg body weight. Likewise, no toxic effects were detected in mice or rats following ingestion of D. candidum extract at a dose level of 4 g/kg/day for thirty days.

Oral administration of D. officinale stems at doses of 25, 1,250, and 2,500 mg/kg did not exhibit any apparent effect on pregnant rats or deformity effects on fetal rats.

7.2 Pharmacopoeial Contraindications

The daily intake should not exceed 12 g according to the Chinese Pharmacopoeia (2020 Edition), and it is not recommended for pregnant and lactating women and infants. According to traditional classification of its thermal tonic property, use is prohibited for patients with wind-heat cold, dampness, and allergies, teenagers, and pregnant women.

7.3 Dendrobine-Specific Pharmacological Cautions

Extracts from Dendrobium contain the chemicals dendrobine, dendroxine, dendramine, and several others. Of these, dendrobine has pharmacologic effects that include analgesic (pain-killing) and anti-fever effects. These pharmacological properties imply that high-dose dendrobine, like many alkaloids, should be approached with caution — particularly given its activity on the central nervous system seen in animal studies. As a dietary supplement ingredient, high doses may pose health risks, including convulsions, seizures, or low blood pressure.

7.4 The Pre-workout Supplement Controversy and Adulteration Concerns

A significant safety concern has arisen from the use of "dendrobium extract" in sports nutrition products. There have been some claims that Dendrobium extracts can contain phenylethylamines (PEAs), a type of stimulant that can have effects similar to those of amphetamines. However, James Neal-Kababick, director of Flora Research Laboratories, who has done extensive research on Dendrobium, stated that he has yet to find any phenylethylamines that are native to Dendrobium.

DEPEA (N,N-diethyl-beta-phenylethylamine) — for which Dendrobium nobile was rumored to be a source — became infamous in the Craze dietary supplement. The FDA issued a warning letter in 2014. In March 2012, the manufacturer of the popular pre-workout supplement Craze (Driven Sports) was the subject of a class action lawsuit, which alleged that the product contained amphetamine drugs, that the product was manufactured in a non-compliant facility, and that dendrobium was a new dietary ingredient (NDI) requiring an NDI notification to FDA.

At least one popular dendrobium-containing supplement (Craze, Driven Sports) was identified by the U.S. Food and Drug Administration (FDA) as being adulterated with a stimulant drug. The critical point established by researchers is that the stimulant compounds associated with safety concerns in these products are not naturally occurring constituents of authentic Dendrobium plant material — they appear to have been synthetically added adulterants.

7.5 Regulatory Status and Gaps

The daily intake should not exceed 12 g according to the Chinese Pharmacopoeia (2020 Edition). More clinical studies are in demand for the risk assessment of humans under exposure to Dendrobium officinale. In short, Dendrobium officinale is a relatively safe herbal product with high edibility and various bioactivities. Apart from controlling the safety and quality during plantation, processing, and storage, it is still essential to manage the consumption within an effective but safe dosage and proper duration.

8. Conservation Status

The commercial value of medicinal Dendrobium has placed wild populations under pressure. A high proportion of species native to China from the genus have been used as folk medicine for more than 2,300 years, and rising demand has made sustainable cultivation a critical priority. Cultivated production (tissue culture and greenhouse farming) has expanded significantly to reduce pressure on wild populations, and several species are now listed on CITES appendices due to threats from over-harvesting.

9. Summary Assessment

Dendrobium nobile Lindl., a well-known precious herb, has a long history of use as a medicine and health food in China. The main chemical components of Dendrobium are alkaloids, aromatic compounds, sesquiterpenoids, and polysaccharides, with multiple biological activities, including immunomodulatory, neuroprotective, and anti-tumor effects.

Although its therapeutic properties are supported by preclinical and clinical studies, further research is needed to understand its mechanisms of action, establish quality control measures, and integrate traditional knowledge with modern research. Dendrobium officinale could be considered a potential agent of adjuvant supplements for disease treatment. However, most studies have focused on crude polysaccharides as the major medicinal compound, and few new components have been purified for further investigation.

In the context of the sports supplement market, the plant's reputation has been complicated by documented adulteration of commercial products with synthetic stimulants not present in authentic plant material. The traditional preparation and pharmacopoeial-compliant use of Dendrobium stems — as a food-medicine tonic — remains distinct from the unsubstantiated performance-enhancement claims associated with such products.

References

• PubMed: Research advances in chemical constituents and pharmacological activities of Dendrobium plants (2022)
• PMC: Evaluation of Chemical Constituents and Important Mechanism of Pharmacological Biology in Dendrobium Plants (2015)
• Dendrobium nobile Lindl: A Review on Its Chemical Constituents and Bioactivities — Chinese Medicine and Culture (2021)
• Traditional uses, chemical compositions and pharmacological activities of Dendrobium: A review — ScienceDirect (2023)
• Chemistry, bioactivity and quality control of Dendrobium — Phytochemistry Reviews, Springer (2013)
• An assessment of the Chinese medicinal Dendrobium industry: Supply, demand and sustainability — ScienceDirect (2018)
• PMC: Therapeutic potential of the chemical composition of Dendrobium nobile Lindl (2023)
• PMC: Identification, Biological Activities and Biosynthetic Pathway of Dendrobium Alkaloids (2021)
• PMC: The Chemical Structure and Pharmacological Activity of Sesquiterpenoids in Dendrobium Sw (2024)
• PMC: Chemical Constituents and Hypoglycemic Mechanisms of Dendrobium nobile in Treatment of Type 2 Diabetic Rats (2023)
• PMC: Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer's disease models (2021)
• PMC: Dendrobine Ameliorates Alzheimer's Disease-like Pathology and Cognitive Decline in 3×Tg-AD Mice (2024)
• PMC: Dendrobium Nobile Lindl. Alkaloid Suppresses NLRP3-Mediated Pyroptosis to Alleviate LPS-Induced Neurotoxicity (2022)
• PubMed: Molecular mechanisms underlying the anticancer property of Dendrobium in various systems of the human body (2023)
• Frontiers in Endocrinology: The therapeutic effects of Dendrobium officinale polysaccharides on diabetes mellitus (2025)
• PMC: Dendrobium officinale Polysaccharide Prevents Diabetes via the Regulation of Gut Microbiota in Prediabetic Mice (2023)
• PMC: Bioactivities and Mechanism of Actions of Dendrobium officinale: A Comprehensive Review (2022)
• PMC: Traditional Uses, Phytochemistry, Pharmacology, and Quality Control of Dendrobium officinale (2021)
• PMC: Acute toxicity and cytotoxicity evaluation of Dendrobium moniliforme aqueous extract in vivo and in vitro (2016)
• PMC: Chemical Composition, Edible Safety, and Antioxidant Activity Evaluation of Flowers in Dendrobium chrysotoxum (2025)
• PMC: Extracts of Dendrobium Alleviate Dry Eye Disease in Rat Model by Regulating Aquaporin Expression and MAPKs/NF-κB Signalling (2022)
• PMC: Current advances of Dendrobium officinale polysaccharides in dermatology (2020)
• PMC: General unknown screening, antioxidant and anti-inflammatory potential of Dendrobium macrostachyum Lindl (2016)
• PMC: Bioactive Polysaccharides from Fermented Dendrobium officinale: Structural Insights and Skin Barrier Repair (2025)
• PMC: Mechanisms of Dendrobium officinale polysaccharides in repairing gastric mucosal injuries based on MAPK signaling pathway (2022)
• PMC: Dendrobium officinale Polysaccharides as a Natural Functional Component for Gastric Ulcers in Rats (2024)
• PubMed: Chemical constituents of Dendrobium venustum and their antimalarial and anti-herpetic properties (2014)
• Operation Supplement Safety (OPSS): Dendrobium: Why is it in supplements?
• FDA: DMAA in Products Marketed as Dietary Supplements
• BSCG: Dietary Supplement Ingredient Advisory List
• Food Biomacromolecules: Advances in immunomodulatory effects and mechanisms of Dendrobium officinale polysaccharides (2025)
• CABI Digital Library: Traditional Uses of Dendrobium nobile in Chinese Medicine